13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001214659-24-009309
Total Value
$834.4M
Positions
57
Other Managers
0
Confidential Omitted
No
Holdings (57)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 2,806,980 | $165.0M | 19.77% |
| 2 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 1,241,300 | $49.2M | 5.90% |
| 3 | DIANTHUS THERAPEUTICS INC | DNTH | 1,380,667 | $41.4M | 4.96% |
| 4 | VERONA PHARMA PLC | 925050106 | 2,369,000 | $38.1M | 4.57% |
| 5 | DYNE THERAPEUTICS INC | DYN | 1,242,945 | $35.3M | 4.23% |
| 6 | ARRIVENT BIOPHARMA INC | AVBP | 1,943,836 | $34.7M | 4.16% |
| 7 | INSMED INC | INSM | 1,140,000 | $30.9M | 3.71% |
| 8 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,060,100 | $23.3M | 2.79% |
| 9 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,093,503 | $22.6M | 2.71% |
| 10 | OCULAR THERAPEUTIX INC | OCUL | 2,425,000 | $22.1M | 2.64% |
| 11 | STRUCTURE THERAPEUTICS INC | GPCR | 506,604 | $21.7M | 2.60% |
| 12 | BRIDGEBIO PHARMA INC | BBIO | 690,000 | $21.3M | 2.56% |
| 13 | MIND MEDICINE MINDMED INC | 60255C885 | 2,153,000 | $20.2M | 2.43% |
| 14 | PERSPECTIVE THERAPEUTICS INC | CATX | 14,718,422 | $17.5M | 2.10% |
| 15 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 405,000 | $15.9M | 1.90% |
| 16 | PRAXIS PRECISION MEDICINES I | PRAX | 260,000 | $15.9M | 1.90% |
| 17 | TENAYA THERAPEUTICS INC | TNYA | 2,854,000 | $14.9M | 1.79% |
| 18 | JASPER THERAPEUTICS INC | JSPRW | 500,811 | $14.7M | 1.76% |
| 19 | ANNEXON INC | ANNX | 2,050,000 | $14.7M | 1.76% |
| 20 | CYTOKINETICS INC | CYTK | 194,000 | $13.6M | 1.63% |
| 21 | AEROVATE THERAPEUTICS INC | 008064107 | 403,685 | $11.9M | 1.43% |
| 22 | APELLIS PHARMACEUTICALS INC | APLS | 200,000 | $11.8M | 1.41% |
| 23 | VIRIDIAN THERAPEUTICS INC | VRDN | 620,000 | $10.9M | 1.30% |
| 24 | GOSSAMER BIO INC | GOSS | 9,187,883 | $10.8M | 1.30% |
| 25 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 408,000 | $9.6M | 1.16% |
| 26 | GLYCOMIMETICS INC | 38000Q102 | 3,000,000 | $9.0M | 1.08% |
| 27 | IMMUNOVANT INC | IMVT | 273,289 | $8.8M | 1.06% |
| 28 | TAYSHA GENE THERAPIES INC | TSHA | 3,030,000 | $8.7M | 1.04% |
| 29 | AKERO THERAPEUTICS INC | 00973Y108 | 340,000 | $8.6M | 1.03% |
| 30 | VENTYX BIOSCIENCES INC | 92332V107 | 1,501,114 | $8.3M | 0.99% |
| 31 | CYBIN INC | HELP | 18,604,650 | $7.7M | 0.92% |
| 32 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 250,000 | $7.2M | 0.86% |
| 33 | MINERALYS THERAPEUTICS INC | MLYS | 550,000 | $7.1M | 0.85% |
| 34 | SILENCE THERAPEUTICS PLC | SLNCF | 315,000 | $6.8M | 0.82% |
| 35 | PEPGEN INC | PEPG | 376,117 | $5.5M | 0.66% |
| 36 | VINCERX PHARMA INC | VNCE | 1,000,000 | $5.1M | 0.61% |
| 37 | NUVATION BIO INC | NUVB | 1,374,870 | $5.0M | 0.60% |
| 38 | PHATHOM PHARMACEUTICALS INC | PHAT | 455,000 | $4.8M | 0.58% |
| 39 | MERSANA THERAPEUTICS INC | 59045L106 | 1,000,000 | $4.5M | 0.54% |
| 40 | TERNS PHARMACEUTICALS INC | TERN | 625,000 | $4.1M | 0.49% |
| 41 | FATE THERAPEUTICS INC | FATE | 520,800 | $3.8M | 0.46% |
| 42 | RENEO PHARMACEUTICALS INC | 75974E103 | 2,250,000 | $3.7M | 0.45% |
| 43 | ANAPTYSBIO INC | ANABV | 165,000 | $3.7M | 0.45% |
| 44 | SANA BIOTECHNOLOGY INC | SANA | 360,800 | $3.6M | 0.43% |
| 45 | AN2 THERAPEUTICS INC | ANTX | 1,103,000 | $3.6M | 0.43% |
| 46 | ALLOGENE THERAPEUTICS INC | ALLO | 720,000 | $3.2M | 0.39% |
| 47 | ALLOVIR INC | 019818103 | 4,200,000 | $3.2M | 0.38% |
| 48 | VERU INC | VERU | 3,800,000 | $2.7M | 0.32% |
| 49 | RAPT THERAPEUTICS INC | 75382E109 | 292,000 | $2.6M | 0.31% |
| 50 | NKARTA INC | NKTX | 240,000 | $2.6M | 0.31% |
| 51 | HELIX ACQUISITION CORP II | HLXC | 250,000 | $2.6M | 0.31% |
| 52 | POSEIDA THERAPEUTICS INC | 73730P108 | 736,000 | $2.3M | 0.28% |
| 53 | CENTURY THERAPEUTICS INC | IPSC | 540,000 | $2.3M | 0.27% |
| 54 | ADICET BIO INC | ACET | 767,799 | $1.8M | 0.22% |
| 55 | ATYR PHARMA INC | ATYR | 700,000 | $1.4M | 0.16% |
| 56 | AUTOLUS THERAPEUTICS PLC | AUTL | 176,000 | $1.1M | 0.13% |
| 57 | CABALETTA BIO INC | CABA | 52,000 | $887,120 | 0.11% |